Medela Potentia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Medela Potentia Tbk. trades at Rp208 (market cap 2.89T, 269K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 4.3× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.57M versus 269K). Which is the better fit depends on your goals.
| MDLA | RSCH | |
|---|---|---|
Market Cap | 2.89T | 678.4B |
Volume | 269K | 25.57M |
Lot | 2.69K | 255.67K |
Turnover | 55.76M | 6.57B |
Average Price | 207.28 | 256.8 |
Value | 55.76M | 6.57B |
Indicative Equilibrium Price | 208 | 258 |
Indicative Equilibrium Volume | 15 | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.
Read more on MDLA →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →